161 results on '"Chapuy-Regaud, Sabine"'
Search Results
2. Hepatitis E virus infections in Europe
3. A fully automated system using transcription-mediated amplification for the molecular diagnosis of hepatitis E virus in human blood and faeces
4. Kinetics of anti-ZIKV antibodies after Zika infection using two commercial enzyme-linked immunoassays
5. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population
6. Current immunoassays and detection of antibodies elicited by Omicron SARS‐CoV‐2 infection
7. Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
8. Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
9. Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response
10. Hepatitis E Virus Reinfections in Solid-Organ-Transplant Recipients Can Evolve Into Chronic Infections
11. Diagnostic Performance of an Automated System for Assaying Anti-Hepatitis E Virus Immunoglobulins M and G Compared with a Conventional Microplate Assay
12. Antibody titers and breakthrough infections with Omicron SARS-CoV-2
13. Casirivimab–imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients
14. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
15. Current immunoassays and detection of antibodies elicited by Omicron SARS‐CoV‐2 infection.
16. Vectorial Release of Human RNA Viruses from Epithelial Cells
17. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
18. Zika virus infection and prolonged viremia in whole-blood specimens
19. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration
20. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration
21. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
22. Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein
23. Classification of the Zoonotic Hepatitis E Virus Genotype 3 Into Distinct Subgenotypes
24. Autoanticorps anti-protéines “citrullinées” dans la polyarthrite rhumatoïde
25. Competence regulation by oxygen availability and by Nox is not related to specific adjustment of central metabolism in streptococcus pneumoniae
26. Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity
27. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation
28. Hepatitis E virus: from the infected organism to the cellular response
29. Intérêt clinique et rôle physiopathologique de la réponse auto-immune contre les protéines citrullinées dans la polyarthrite rhumatoïde
30. Detection of Antibodies to Deiminated Recombinant Rat Filaggrin by Enzyme-Linked Immunosorbent Assay: A Highly Effective Test for the Diagnosis of Rheumatoid Arthritis
31. Competence regulation by oxygen in Streptococcus pneumoniae : involvement of ciaRH and comCDE
32. The NADH oxidase of Streptococcus pneumoniae: its involvement in competence and virulence
33. Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes
34. Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response
35. Zika virus in semen and spermatozoa
36. Virus de l'hépatite E : de l'organisme infecté à la réponse cellulaire.
37. Hepatitis E Pathogenesis
38. Zika virus in semen of a patient returning from a non-epidemic area
39. Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection
40. Temporal evolution of the distribution of hepatitis E virus genotypes in Southwestern France
41. Hepatitis E Virus
42. Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients
43. Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration.
44. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients
45. Progesterone and a phospholipase inhibitor increase the endosomal bis(monoacylglycero)phosphate content and block HIV viral particle intercellular transmission
46. Performance of Two Commercial Assays for Detecting Hepatitis E Virus RNA in Acute or Chronic Infections
47. Full-length genome sequences of hepatitis C virus subtype 4f
48. New Natural Intergenotypic (2/5) Recombinant of Hepatitis C Virus
49. Fibrin Deimination in Synovial Tissue Is Not Specific for Rheumatoid Arthritis but Commonly Occurs during Synovitides
50. Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.